Within the central nervous system, GLP-1RAs function to reduce hunger sensations, suppress appetite, lower caloric intake, amplify satiety, and facilitate better management of eating behaviors (98102)
These conditions alter the subcutaneous tissue architecture and can affect medication absorption
Moreover, seleno-GPxs being the antioxidant enzymes have also been investigated for their involvement in regulating the radiosensitivity/radioresistance of cancerous and non-cancerous cell types [51,52,53,54,55,56, 67]
On our model: At Rivas, the large majority of our GLP-1 patients use compounded semaglutide or compounded tirzepatide, drawn from vials and administered in-office by their provider at each visit
Let us help you achieve a healthier you
Dickinson DA, Forman HJ (2002) Cellular glutathione and thiols metabolism